Quarterly Activities and Cashflow Report
ADELAIDE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO,), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteri
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersRedhill Biopharma (NASDAQ:RDHL) stock rose 35.0% to $0.25 during Friday's pre-market session. The market value of their outstanding shares is at $22.6 million. Akanda (NASDAQ:AKAN) stock moved
Short Interest in Bionomics Limited (NASDAQ:BNOX) Rises By 150.0%
Bionomics Limited (NASDAQ:BNOX – Get Rating) was the recipient of a large growth in short interest during the month of December. As of December 30th, there was short interest totalling 1,000 shares,
Bionomics Limited (OTCMKTS:BNOEF) Short Interest Down 34.9% in December
Bionomics Limited (OTCMKTS:BNOEF – Get Rating) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 116,500 shares, a decrease
Bionomics (NASDAQ:BNOX) Downgraded by HC Wainwright to Neutral
HC Wainwright downgraded shares of Bionomics (NASDAQ:BNOX – Get Rating) from a buy rating to a neutral rating in a report issued on Monday, The Fly reports. Separately, Loop Capital initiated coverag
Bionomics Limited (NASDAQ:BNOX) Given Consensus Rating of "Moderate Buy" by Analysts
Bionomics Limited (NASDAQ:BNOX – Get Rating) has been given a consensus rating of "Moderate Buy" by the six analysts that are presently covering the firm, MarketBeat Ratings reports. Two equities re
Bionomics (NASDAQ:BNOX) Given "In-Line" Rating at Evercore ISI
Evercore ISI restated their in-line rating on shares of Bionomics (NASDAQ:BNOX – Get Rating) in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has a $6.00 price target
Bionomics' (BNOX) "In-Line" Rating Reaffirmed at Evercore ISI
Bionomics (NASDAQ:BNOX – Get Rating)'s stock had its "in-line" rating reaffirmed by Evercore ISI in a note issued to investors on Tuesday, Benzinga reports. They currently have a $6.00 price target o
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
UpgradesCanaccord Genuity upgraded the previous rating for Nevro Corp (NYSE:NVRO) from Hold to Buy. In the third quarter, Nevro showed an EPS of $0.59, compared to $0.87 from the year-ago quarter. The
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
Wells Fargo raised Ross Stores, Inc. (NASDAQ:ROST) price target from $120 to $135. Wells Fargo analyst Ike Boruchow maintained an Overweight rating on the stock. Ross Stores shares fell 0.9% to clo
Loading...
No Stock Yet